Efficacy and safety of the G protein‐coupled receptor 119 agonist DS‐8500a in Japanese type 2 diabetes mellitus patients with inadequate glycemic control on sitagliptin: A phase 2 randomized placebo‐controlled study

INTRODUCTION: We evaluated the efficacy and safety of DS‐8500a as add‐on therapy to sitagliptin in Japanese type 2 diabetes mellitus patients. MATERIALS AND METHODS: This multicenter, randomized, double‐blind, placebo‐controlled, phase 2 trial randomized patients aged ≥20 years with hemoglobin A1c ≥...

Descripción completa

Detalles Bibliográficos
Autores principales: Terauchi, Yasuo, Yamada, Yuichiro, Watada, Hirotaka, Nakatsuka, Yasuhiko, Shiosakai, Kazuhito, Washio, Takuo, Taguchi, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215943/
https://www.ncbi.nlm.nih.gov/pubmed/29607623
http://dx.doi.org/10.1111/jdi.12846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215943/
https://www.ncbi.nlm.nih.gov/pubmed/29607623
http://dx.doi.org/10.1111/jdi.12846

Ejemplares similares